SAI Life Sciences Ltd Executive and Leadership Team

Ravi Badgi, the Chief Executive Officer at SAI Life Sciences Ltd, directs the overarching corporate strategy and long-term vision for the organization. Badgi manages the integration of complex drug discovery and development services to ensure alignment with global pharmaceutical market demands. By overseeing high-level resource allocation, the Chief Executive Officer optimizes internal processes to support rapid NCE formulation and generic development cycles. This leadership role involves constant collaboration with the Board to refine business models and expand the company's footprint across international markets. Ravi Badgi maintains a focus on operational excellence, ensuring that all departments meet stringent quality standards while driving sustainable growth. Through strategic decision-making, the Chief Executive Officer secures the competitive position of the firm within the biotechnology sector, ultimately fostering innovation and delivering value to clients through advanced scientific capabilities and robust manufacturing infrastructure.

Krishna Kanumuri, the Chief Executive Officer & Managing Director at SAI Life Sciences Ltd, architects the primary business trajectory and governance framework for the entire enterprise. Kanumuri drives the expansion of synthetic and medicinal chemistry services, ensuring that the company remains at the forefront of pharmaceutical innovation. Overseeing the execution of large-scale manufacturing initiatives, the Chief Executive Officer & Managing Director aligns corporate objectives with the evolving needs of global biotechnology partners. This role requires constant engagement with executive leadership to streamline cross-functional workflows and enhance service delivery efficiency. Krishna Kanumuri prioritizes the development of advanced R&D capabilities, positioning the firm as a preferred partner for complex drug development projects. By fostering a culture of scientific rigor and operational agility, the Chief Executive Officer & Managing Director ensures that the organization achieves consistent growth while maintaining high standards of quality and compliance across all regional operations.

Maneesh Pingle, the President, Discovery at SAI Life Sciences Ltd, directs the strategic operations and scientific growth of the discovery division. Pingle oversees the expansion of biology and medicinal chemistry services, ensuring that the company provides cutting-edge solutions for drug discovery partners. By managing the research portfolio, the President, Discovery aligns technical capabilities with the evolving requirements of the global pharmaceutical market. This role involves fostering innovation within the laboratory teams and ensuring that all discovery projects achieve high-quality results. Maneesh Pingle collaborates with other executive leaders to integrate discovery services with downstream development and manufacturing processes. Through effective leadership and a focus on scientific advancement, the President, Discovery drives the success of the company's research initiatives, ensuring that the organization remains a leader in providing comprehensive drug discovery services to the biotechnology industry worldwide.

Gautham Manoj, the Chief of Staff at SAI Life Sciences Ltd, coordinates internal operations and facilitates communication between the executive leadership team and various functional departments. Manoj manages strategic initiatives that improve organizational efficiency and ensure that corporate goals remain synchronized across all business units. By overseeing the implementation of key management projects, the Chief of Staff supports the seamless execution of drug discovery and development workflows. This role involves analyzing operational data to identify bottlenecks and recommending solutions that enhance productivity. Gautham Manoj works closely with the C-suite to translate high-level strategy into actionable tasks, ensuring that the company maintains its competitive edge in the pharmaceutical services market. Through meticulous planning and cross-departmental coordination, the Chief of Staff drives the successful completion of critical business objectives, ultimately contributing to the overall growth and stability of the organization in a fast-paced industry environment.

Anil Chilagani, the Chief Revenue Officer, Agm Disovery Oe Lead ( Business) at SAI Life Sciences Ltd, directs the commercial strategy and revenue growth initiatives for the discovery services division. Chilagani manages client relationships and identifies new market opportunities to expand the reach of medicinal chemistry and biology services. By overseeing the business development pipeline, the Chief Revenue Officer, Agm Disovery Oe Lead ( Business) ensures that the company captures significant market share in the global pharmaceutical sector. This role involves aligning sales efforts with technical capabilities to provide tailored solutions for biotechnology partners. Anil Chilagani monitors revenue performance and implements strategies to optimize the sales funnel, ensuring consistent financial growth. Through proactive engagement with potential clients and internal teams, the Chief Revenue Officer, Agm Disovery Oe Lead ( Business) secures long-term partnerships that support the company's mission of accelerating drug discovery and development processes.

Anindya Manna, the A. R. Scientist. Chief Revenue Officer. Drug Discovery and Development. MedChem at SAI Life Sciences Ltd, leads the scientific and commercial integration of medicinal chemistry projects. Manna directs the application of advanced chemical synthesis techniques to solve complex drug development challenges for global clients. By overseeing the technical execution of discovery programs, the A. R. Scientist. Chief Revenue Officer. Drug Discovery and Development. MedChem ensures that scientific outcomes align with commercial revenue targets. This role requires balancing high-level research objectives with the financial requirements of the business, facilitating a seamless transition from laboratory discovery to commercial manufacturing. Anindya Manna collaborates with cross-functional teams to refine methodologies and improve the efficiency of NCE formulation services. Through technical leadership and strategic revenue management, the A. R. Scientist. Chief Revenue Officer. Drug Discovery and Development. MedChem drives the success of critical research initiatives, ensuring that the company delivers high-value scientific solutions to the pharmaceutical industry.

Khursheed Syed, the Chief of Staff - CMC at SAI Life Sciences Ltd, manages the operational coordination of Chemistry, Manufacturing, and Controls (CMC) activities. Syed oversees the integration of pre-formulation and generic formulation development processes to ensure that all projects meet regulatory and quality standards. By directing the flow of information between technical teams and executive leadership, the Chief of Staff - CMC ensures that manufacturing timelines remain on track. This role involves optimizing resource allocation within the CMC department to support the company's broader drug development mission. Khursheed Syed monitors project milestones and implements process improvements that enhance the speed and reliability of manufacturing services. Through effective management and strategic oversight, the Chief of Staff - CMC ensures that the organization maintains its reputation for excellence in pharmaceutical manufacturing, ultimately supporting the successful delivery of complex drug products to global markets.

Poornachandar Accha, the Chief Medical Officer at SAI Life Sciences Ltd, directs the clinical and medical strategy for the company's drug development services. Accha oversees the scientific integrity of clinical programs, ensuring that all research and development activities adhere to global medical standards and regulatory requirements. By providing expert guidance on therapeutic areas, the Chief Medical Officer supports the design and execution of complex biology and pre-formulation studies. This role involves collaborating with internal research teams to validate the safety and efficacy of new chemical entities. Poornachandar Accha ensures that the company's scientific output remains relevant to the needs of the pharmaceutical and biotechnology sectors. Through clinical leadership and strategic oversight, the Chief Medical Officer drives the success of development projects, ensuring that the organization provides high-quality medical insights that facilitate the transition of drug candidates from the laboratory to clinical application.